Cutting edge: Flt3 ligand mediates STAT3-Independent expansion but STAT3-Dependent activation of myeloid-derived suppressor cells

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3470-3473

  Rosborough, Brian R ^a   Mathews, Lisa R ^a,b   Matta, Benjamin M ^a   Liu, Quan ^a,c   Raïch Regue, Dàlia ^a   Thomson, Angus W ^a,d   Turnquist, Heth R ^a,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c HARBIN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; DENDRITIC CELLS; GRAFT SURVIVAL; IMMUNOPHENOTYPING; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MYELOID CELLS; PHENOTYPE; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTE SUBSETS;

EID: 84898642115     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300058     Document Type: Article

References (25)

1. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
2. Youn, J.-I., and D. I. Gabrilovich. 2010. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 40: 2969-2975.
3. Lees, J. R., A. M. Azimzadeh, and J. S. Bromberg. 2011. Myeloid derived suppressor cells in transplantation. Curr. Opin. Immunol. 23: 692-697.
4. Serafini, P., R. Carbley, K. A. Noonan, G. Tan, V. Bronte, and I. Borrello. 2004. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64: 6337-6343.
5. Lechner, M. G., D. J. Liebertz, and A. L. Epstein. 2010. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185: 2273-2284.
6. Adolfsson, J., O. J. Borge, D. Bryder, K. Theilgaard-Mönch, I. Astrand-Grundström, E. Sitnicka, Y. Sasaki, and S. E. Jacobsen. 2001. Upregulation of Flt3 expression within the bone marrow Lin(2)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15: 659-669.
7. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184: 1953-1962.
8. McKenna, H. J., K. L. Stocking, R. E. Miller, K. Brasel, T. De Smedt, E. Maraskovsky, C. R. Maliszewski, D. H. Lynch, J. Smith, B. Pulendran, et al. 2000. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95: 3489-3497.
9. O'Keeffe, M., H. Hochrein, D. Vremec, J. Pooley, R. Evans, S. Woulfe, and K. Shortman. 2002. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99: 2122-2130.
10. Laouar, Y., T. Welte, X. Y. Fu, and R. A. Flavell. 2003. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 19: 903-912.
11. Mir, S. A., A. Chatterjee, A. Mitra, K. Pathak, S. K. Mahata, and S. Sarkar. 2012. Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. J. Biol. Chem. 287: 2666-2677.
12. Rosborough, B. R., A. Castellaneta, S. Natarajan, A. W. Thomson, andH. R. Turnquist. 2012. Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloidderived suppressor cells in vitro and in vivo. J. Leukoc. Biol. 91: 701-709.
13. Turnquist, H. R., J. Cardinal, C. Macedo, B. R. Rosborough, T. L. Sumpter, D. A. Geller, D. Metes, and A. W. Thomson. 2010. mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS. Blood 115: 4758-4769.
14. Turnquist, H. R., Z. Zhao, B. R. Rosborough, Q. Liu, A. Castellaneta, K. Isse, Z. Wang, M. Lang, D. B. Stolz, X. X. Zheng, et al. 2011. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J. Immunol. 187: 4598-4610.
15. Darrasse-Jéze, G., S. Deroubaix, H. Mouquet, G. D. Victora, T. Eisenreich, K. H. Yao, R. F. Masilamani, M. L. Dustin, A. Rudensky, K. Liu, and M. C. Nussenzweig. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206: 1853-1862.
16. Solheim, J. C., A. J. Reber, A. E. Ashour, S. Robinson, M. Futakuchi, S. G. Kurz, K. Hood, R. R. Fields, L. R. Shafer, D. Cornell, et al. 2007. Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection. Cancer Gene Ther. 14: 364-371.
17. Waight, J. D., C. Netherby, M. L. Hensen, A. Miller, Q. Hu, S. Liu, P. N. Bogner, M. R. Farren, K. P. Lee, K. Liu, and S. I. Abrams. 2013. Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. J. Clin. Invest. 123: 4464-4478.
18. De Wilde, V., N. Van Rompaey, M. Hill, J. F. Lebrun, P. Lemaître, F. Lhommé, C. Kubjak, B. Vokaer, G. Oldenhove, L. M. Charbonnier, et al. 2009. Endotoxininduced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am. J. Transplant. 9: 2034-2047.
19. Mougiakakos, D., R. Jitschin, L. von Bahr, I. Poschke, R. Gary, B. Sundberg, A. Gerbitz, P. Ljungman, and K. Le Blanc. 2013. Immunosuppressive CD14+HLADR low/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Leukemia 27: 377-388.
20. Highfill, S. L., P. C. Rodriguez, Q. Zhou, C. A. Goetz, B. H. Koehn, R. Veenstra, P. A. Taylor, A. Panoskaltsis-Mortari, J. S. Serody, D. H. Munn, et al. 2010. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116: 5738-5747.
21. Zhang, W., S. Liang, J. Wu, and A. Horuzsko. 2008. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 86: 1125-1134.
22. Garcia, M. R., L. Ledgerwood, Y. Yang, J. Xu, G. Lal, B. Burrell, G. Ma, D. Hashimoto, Y. Li, P. Boros, et al. 2010. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J. Clin. Invest. 120: 2486-2496.
23. Eto, M., H. Hackstein, K. Kaneko, K. Nomoto, and A. W. Thomson. 2002. Promotion of skin graft tolerance across MHC barriers by mobilization of dendritic cells in donor hemopoietic cell infusions. J. Immunol. 169: 2390-2396.
24. Blazar, B. R., H. J. McKenna, A. Panoskaltsis-Mortari, and P. A. Taylor. 2001. Flt3 ligand (FL) treatment of murine donors does not modify graft-versus-host disease (GVHD) but FL treatment of recipients post-bone marrow transplantation accelerates GVHD lethality. Biol. Blood Marrow Transplant. 7: 197-207.
25. Wang, Z., T. Taner, A. E. Morelli, and A. W. Thomson. 2005. Hosts lacking fmslike tyrosine kinase 3 ligand exhibit marked reductions in transplant vascular sclerosis. Transplantation 79: 869-875.